Zhongyuan Kyowa: Announcement of Zhongyuan Kyowa Cytogenetic Engineering Co., Ltd. on obtaining a notice of acceptance of the wholly-owned subsidiary drug clinical trial application

SZSI · Sep 27

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.